SEARCH BY NAME

BROWSE

Browse Australian delisted companies0-9A BC DE F GH IJ KL MN OP QR ST UV WX YZ
Browse terminated Australian managed funds0-9A BC DE FGH IJ KL MN OP QR ST UV WX YZ

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

BIOSIGNAL LIMITED (BOS)

Former Name ASX

SHARE PRICES

Former (or subsequent) names

 FROMTO
ONE NORTH ENTERTAINMENT LIMITED29/12/2011
RGM MEDIA LIMITED03/08/201029/12/2011
BIOSIGNAL LIMITED05/04/200403/08/2010
CTI COMMUNICATIONS LIMITED05/04/2004

Shareholder links

Our website ranking of BOS: rating 2
(2 out of 5)
COMPANY WEBSITE:

 

REGISTRY:
Boardroom Pty Ltd, Level 12, 225 George Street, Sydney NSW 2000
Tel : +61 2 9290 9600 or 1300 737 760
Fax : +61 2 9279 0664 or 1300 653 459
RegistryWebsite RegistryEmail

Company details

Address: Suite 145, Level 1 , National Innovation Centre , Australian Technology Park , EVELEIGH , NSW, AUSTRALIA, 1430
Tel:  (02) 9209 4126 Fax: (02) 9209 4306

Date first listed: 28/06/2000
Company Secretary: Mr Timothy Morrison
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Human health research and development
name changed to RGM Media Limited03/08/2010
the Company advises that ASX has approved an application by the Company for an additional waiver from listing rule 14.7 allowing the Company to issue the shares and options listed below more than 3 months and 1 month (as applicable) after the date of shareholder approval at a General Meeting held on 19 March 2010. The shares and options are as follows: • 70,000,000 fully paid ordinary shares to RGM Entertainment Pte Ltd for the Company's acquisition of RGM Group Pte Ltd; • Up to 30,000,000 fully paid ordinary shares under the Company's prospectus dated 21 April 2010 ("the Prospectus"); and • 200,000 fully paid shares and 200,000 unlisted options to Ayre Nominees Pty Ltd.29/07/2010
advises that ASX has approved an application by the Company for a waiver from listing rule 14.7 allowing the Company to issue the shares and options listed below more than 3 months and 1 month (as applicable) after the date of shareholder approval at a General Meeting held on 19 March 2010. The shares and options are as follows: • 70,000,000 fully paid ordinary shares to RGM Entertainment Pte Ltd for the Company's acquisition of RGM Group Pte Ltd; • Up to 30,000,000 fully paid ordinary shares under the Company's prospectus dated 21 April 2010; and • 200,000 fully paid shares and 200,000 unlisted options to Ayre Nominees Pty Ltd25/06/2010
issues a Supplementary Prospectus18/05/2010
issues a Supplementary Prospectus04/05/2010
issues a prospectus for the issue of 20 million Shares at an issue price of twenty cents ($0.20) each to raise $4 million, with the ability to accept oversubscriptions for up to an additional 10 million Shares ($2 million) before costs of the Offer22/04/2010
advises that the 25:1 consolidation of Biosignal's issued capital has been completed07/04/2010
suspended from quotation immediately, at the request of the Company, pursuant to listing rule 17.3 and paragraph 44 of Guidance Note 12 - Changes to Activities, following shareholder approval for the acquisition of RGM Entertainment Pte Ltd19/03/2010
securities reinstated11/02/2010
all resolutions considered at the AGM on 18 December 2009 were carried as ordinary resolutions on a show of hands08/01/2010
company signs an equity financing agreement14/12/2009
provides Notice of Annual General Meeting to be held on 18 December20/11/2009
releases Annual Report06/11/2009
signals there will be a delay in finalising the annual report30/09/2009
the company has agreed to buy RGM Group Pte Ltd - the transaction values RGM at $35m25/09/2009
company advises it has raised $900k by way of a convertible note21/09/2009
company is making "substantial progess" towards the purchase of assets of RGM Entertainment Pte Ltd02/09/2009
company releases its Preliminary Final Report31/08/2009
the company has entered into revised definitive agreements with Commonwealth Biotechnologies Inc (NASDAQ:CBTE) for the sale of the BOS biofilm Intellectual Property03/08/2009
the securities of Biosignal Limited (the "Company") will be suspended from quotation immediately, at the request of the Company following the Company announcing an agreement with RGM Entertainment Pte Ltd31/07/2009
name changed from CTI Communications Limited05/04/2004

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

     

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Bruce FoyNon Exec Director
    Timothy BoydDirector

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Michael OredssonManaging Director, CEO10/08/2007
    Michael TavernerDirector26/03/2007
    Gillian TurnerDirector24/11/2006

    Date of first appointment, title may have changed.